Loading...

LANXESS

WBAG:LXS
Snowflake Description

Proven track record with adequate balance sheet and pays a dividend.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
LXS
WBAG
€5B
Market Cap
  1. Home
  2. AT
  3. Materials
Company description

LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. The last earnings update was 35 days ago. More info.


Add to Portfolio Compare Print
LXS Share Price and Events
7 Day Returns
5.2%
WBAG:LXS
2.9%
Europe Chemicals
3.4%
AT Market
1 Year Returns
-11.9%
WBAG:LXS
-1.6%
Europe Chemicals
-2%
AT Market
LXS Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
LANXESS (LXS) 5.2% 5.9% 11.9% -11.9% - -
Europe Chemicals 2.9% 4.4% 11.7% -1.6% 21.6% 27.3%
AT Market 3.4% 6% 10.1% -2% 43.4% 29.5%
1 Year Return vs Industry and Market
  • LXS underperformed the Chemicals industry which returned -1.6% over the past year.
  • LXS underperformed the Market in Austria which returned -2% over the past year.
Price Volatility
LXS
Industry
5yr Volatility vs Market

LXS Value

 Is LANXESS undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of LANXESS to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for LANXESS.

WBAG:LXS Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 23 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 7.6%
Perpetual Growth Rate 10-Year AT Government Bond Rate 0.5%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for WBAG:LXS
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year AT Govt Bond Rate 0.5%
Equity Risk Premium S&P Global 6%
Chemicals Unlevered Beta Simply Wall St/ S&P Global 0.93
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.931 (1 + (1- 30%) (55.57%))
1.197
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.2
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.51% + (1.197 * 5.96%)
7.64%

Discounted Cash Flow Calculation for WBAG:LXS using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for LANXESS is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

WBAG:LXS DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (EUR, Millions) Source Present Value
Discounted (@ 7.64%)
2019 271.00 Analyst x7 251.76
2020 298.59 Analyst x9 257.69
2021 329.86 Analyst x7 264.47
2022 388.00 Analyst x3 288.99
2023 408.67 Analyst x3 282.77
2024 424.14 Est @ 3.79% 272.65
2025 436.04 Est @ 2.8% 260.39
2026 445.26 Est @ 2.12% 247.02
2027 452.54 Est @ 1.63% 233.23
2028 458.41 Est @ 1.3% 219.48
Present value of next 10 years cash flows €2,578.45
WBAG:LXS DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= €458.41 × (1 + 0.51%) ÷ (7.64% – 0.51%)
€6,459.36
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= €6,459.36 ÷ (1 + 7.64%)10
€3,092.66
WBAG:LXS Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= €2,578.45 + €3,092.66
€5,671.10
Equity Value per Share
(EUR)
= Total value / Shares Outstanding
= €5,671.10 / 90.24
€62.85
WBAG:LXS Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in WBAG:LXS represents 0.99745x of XTRA:LXS
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.99745x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (EUR) x Listing Adjustment Factor
= € 62.85 x 0.99745
€62.69
Value per share (EUR) From above. €62.69
Current discount Discount to share price of €54.60
= -1 x (€54.60 - €62.69) / €62.69
12.9%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price LANXESS is available for.
Intrinsic value
13%
Share price is €54.6 vs Future cash flow value of €62.69
Current Discount Checks
For LANXESS to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • LANXESS's share price is below the future cash flow value, but not at a moderate discount (< 20%).
  • LANXESS's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for LANXESS's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are LANXESS's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
WBAG:LXS PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in EUR €1.97
XTRA:LXS Share Price ** XTRA (2019-04-18) in EUR €54.74
Europe Chemicals Industry PE Ratio Median Figure of 93 Publicly-Listed Chemicals Companies 18.75x
Austria Market PE Ratio Median Figure of 51 Publicly-Listed Companies 14.73x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of LANXESS.

WBAG:LXS PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= XTRA:LXS Share Price ÷ EPS (both in EUR)

= 54.74 ÷ 1.97

27.83x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • LANXESS is overvalued based on earnings compared to the Europe Chemicals industry average.
  • LANXESS is overvalued based on earnings compared to the Austria market.
Price based on expected Growth
Does LANXESS's expected growth come at a high price?
Raw Data
WBAG:LXS PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 27.83x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 23 Analysts
16.3%per year
Europe Chemicals Industry PEG Ratio Median Figure of 62 Publicly-Listed Chemicals Companies 1.89x
Austria Market PEG Ratio Median Figure of 32 Publicly-Listed Companies 1.34x

*Line of best fit is calculated by linear regression .

WBAG:LXS PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 27.83x ÷ 16.3%

1.71x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • LANXESS is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on LANXESS's assets?
Raw Data
WBAG:LXS PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in EUR €30.37
XTRA:LXS Share Price * XTRA (2019-04-18) in EUR €54.74
Europe Chemicals Industry PB Ratio Median Figure of 138 Publicly-Listed Chemicals Companies 1.85x
Austria Market PB Ratio Median Figure of 59 Publicly-Listed Companies 1.27x
WBAG:LXS PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= XTRA:LXS Share Price ÷ Book Value per Share (both in EUR)

= 54.74 ÷ 30.37

1.8x

* Primary Listing of LANXESS.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • LANXESS is good value based on assets compared to the Europe Chemicals industry average.
X
Value checks
We assess LANXESS's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check)
  5. LANXESS has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

LXS Future Performance

 How is LANXESS expected to perform in the next 1 to 3 years based on estimates from 23 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
16.3%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is LANXESS expected to grow at an attractive rate?
  • LANXESS's earnings growth is expected to exceed the low risk savings rate of 0.5%.
Growth vs Market Checks
  • LANXESS's earnings growth is expected to exceed the Austria market average.
  • LANXESS's revenue growth is positive but not above the Austria market average.
Annual Growth Rates Comparison
Raw Data
WBAG:LXS Future Growth Rates Data Sources
Data Point Source Value (per year)
WBAG:LXS Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 23 Analysts 16.3%
WBAG:LXS Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 23 Analysts 2.7%
Europe Chemicals Industry Earnings Growth Rate Market Cap Weighted Average 10%
Europe Chemicals Industry Revenue Growth Rate Market Cap Weighted Average 3.5%
Austria Market Earnings Growth Rate Market Cap Weighted Average 9%
Austria Market Revenue Growth Rate Market Cap Weighted Average 2.7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
WBAG:LXS Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 23 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
WBAG:LXS Future Estimates Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31 8,281 846 474 4
2022-12-31 8,011 808 437 4
2021-12-31 7,747 814 358 18
2020-12-31 7,484 777 324 23
2019-12-31 7,279 735 297 22
WBAG:LXS Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2018-12-31 7,197 586 180
2018-09-30 10,200 603 208
2018-06-30 10,124 737 202
2018-03-31 10,007 881 127
2017-12-31 6,530 868 23
2017-09-30 6,810 692 73
2017-06-30 7,021 627 83
2017-03-31 7,252 651 166
2016-12-31 7,699 689 192
2016-09-30 7,590 882 205
2016-06-30 7,622 768 184
2016-03-31 7,784 707 196

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • LANXESS's earnings are expected to grow by 16.3% yearly, however this is not considered high growth (20% yearly).
  • LANXESS's revenue is expected to grow by 2.7% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
WBAG:LXS Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 23 Analyst Estimates (S&P Global) See Below

All data from LANXESS Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

WBAG:LXS Future Estimates Data
Date (Data in EUR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31 5.25 5.25 5.25 1.00
2022-12-31 4.89 4.89 4.89 1.00
2021-12-31 4.34 5.53 2.71 12.00
2020-12-31 3.84 4.59 2.47 16.00
2019-12-31 3.36 3.77 2.77 15.00
WBAG:LXS Past Financials Data
Date (Data in EUR Millions) EPS *
2018-12-31 1.97
2018-09-30 2.27
2018-06-30 2.21
2018-03-31 1.39
2017-12-31 0.25
2017-09-30 0.80
2017-06-30 0.91
2017-03-31 1.81
2016-12-31 2.10
2016-09-30 2.24
2016-06-30 2.01
2016-03-31 2.14

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • LANXESS is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess LANXESS's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
LANXESS has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

LXS Past Performance

  How has LANXESS performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare LANXESS's growth in the last year to its industry (Chemicals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • LANXESS has delivered over 20% year on year earnings growth in the past 5 years.
  • LANXESS's 1-year earnings growth exceeds its 5-year average (682.6% vs 43.5%)
  • LANXESS's earnings growth has exceeded the Europe Chemicals industry average in the past year (682.6% vs 2.7%).
Earnings and Revenue History
LANXESS's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from LANXESS Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

WBAG:LXS Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 7,197.00 180.00 1,158.00 118.00
2018-09-30 10,200.00 208.00 1,420.00 152.00
2018-06-30 10,124.00 202.00 1,421.00 151.00
2018-03-31 10,007.00 127.00 1,419.00 152.00
2017-12-31 6,530.00 23.00 1,111.00 103.00
2017-09-30 6,810.00 73.00 1,103.00 116.00
2017-06-30 7,021.00 83.00 1,087.00 121.00
2017-03-31 7,252.00 166.00 1,072.00 124.00
2016-12-31 7,699.00 192.00 1,116.00 131.00
2016-09-30 7,590.00 205.00 1,092.00 128.00
2016-06-30 7,622.00 184.00 1,093.00 126.00
2016-03-31 7,784.00 196.00 1,097.00 128.00
2015-12-31 7,902.00 165.00 1,078.00 130.00
2015-09-30 8,000.00 82.00 1,060.00 134.00
2015-06-30 8,087.00 76.00 1,048.00 141.00
2015-03-31 8,001.00 44.00 1,039.00 147.00
2014-12-31 8,006.00 47.00 1,052.00 160.00
2014-09-30 8,116.00 -89.00 1,045.00 176.00
2014-06-30 8,126.00 -113.00 1,059.00 180.00
2014-03-31 8,248.00 -159.00 1,075.00 183.00
2013-12-31 8,300.00 -159.00 1,083.00 186.00
2013-09-30 8,409.00 95.00 1,107.00 179.00
2013-06-30 8,518.00 176.00 1,108.00 185.00
2013-03-31 8,801.00 341.00 1,112.00 195.00
2012-12-31 9,094.00 508.00 1,102.00 192.00
2012-09-30 9,094.00 463.00 1,096.00 186.00
2012-06-30 9,271.00 525.00 1,093.00 177.00

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • LANXESS has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • LANXESS used its assets less efficiently than the Europe Chemicals industry average last year based on Return on Assets.
  • LANXESS has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess LANXESS's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
LANXESS has a total score of 4/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

LXS Health

 How is LANXESS's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up LANXESS's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • LANXESS is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • LANXESS's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of LANXESS's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.4x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from LANXESS Company Filings, last reported 3 months ago.

WBAG:LXS Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 2,773.00 2,745.00 1,339.00
2018-09-30 3,626.00 2,726.00 231.00
2018-06-30 3,429.00 2,830.00 240.00
2018-03-31 3,425.00 2,914.00 538.00
2017-12-31 3,413.00 2,875.00 589.00
2017-09-30 3,496.00 2,849.00 539.00
2017-06-30 3,579.00 3,326.00 763.00
2017-03-31 3,816.00 2,868.00 2,533.00
2016-12-31 3,728.00 2,812.00 571.00
2016-09-30 3,453.00 1,334.00 523.00
2016-06-30 3,435.00 1,581.00 652.00
2016-03-31 2,294.00 1,585.00 333.00
2015-12-31 2,323.00 1,701.00 466.00
2015-09-30 2,188.00 1,778.00 431.00
2015-06-30 2,288.00 1,830.00 432.00
2015-03-31 2,065.00 1,885.00 451.00
2014-12-31 2,161.00 1,880.00 518.00
2014-09-30 2,364.00 1,986.00 520.00
2014-06-30 2,324.00 2,090.00 575.00
2014-03-31 1,892.00 2,436.00 536.00
2013-12-31 1,900.00 2,317.00 533.00
2013-09-30 2,147.00 2,384.00 522.00
2013-06-30 2,198.00 2,421.00 376.00
2013-03-31 2,386.00 2,391.00 536.00
2012-12-31 2,330.00 2,334.00 798.00
2012-09-30 2,313.00 1,940.00 308.00
2012-06-30 2,259.00 1,996.00 242.00
  • LANXESS's level of debt (99%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (122% vs 99% today).
  • Debt is well covered by operating cash flow (21.3%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 8.2x coverage).
X
Financial health checks
We assess LANXESS's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. LANXESS has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

LXS Dividends

 What is LANXESS's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
1.64%
Current annual income from LANXESS dividends. Estimated to be 2.07% next year.
If you bought €2,000 of LANXESS shares you are expected to receive €33 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • LANXESS's pays a higher dividend yield than the bottom 25% of dividend payers in Austria (1.44%).
  • LANXESS's dividend is below the markets top 25% of dividend payers in Austria (4.62%).
Upcoming dividend payment

Purchase LANXESS before the 'Buy Limit' to receive their next dividend payment.

Dividends are usually paid every 3 or 6 months, you can time your share purchase to take advantage of upcoming dividend payments.
Dividend payment calendar
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
WBAG:LXS Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 23 Analyst Estimates (S&P Global) See Below
Europe Chemicals Industry Average Dividend Yield Market Cap Weighted Average of 78 Stocks 3%
Austria Market Average Dividend Yield Market Cap Weighted Average of 49 Stocks 3.4%
Austria Minimum Threshold Dividend Yield 10th Percentile 1.1%
Austria Bottom 25% Dividend Yield 25th Percentile 1.4%
Austria Top 25% Dividend Yield 75th Percentile 4.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

WBAG:LXS Future Dividends Estimate Data
Date (Data in €) Dividend per Share (annual) Avg. No. Analysts
2023-12-31 1.45 2.00
2022-12-31 1.38 2.00
2021-12-31 1.23 18.00
2020-12-31 1.12 22.00
2019-12-31 1.01 22.00
WBAG:LXS Past Annualized Dividends Data
Date (Data in €) Dividend per share (annual) Avg. Yield (%)
2019-03-14 0.900 1.778
2018-03-15 0.800 1.393
2018-01-15 0.800 1.164
2017-03-16 0.700 1.067
2016-03-18 0.600 1.189
2016-03-17 0.600 1.444
2015-03-19 0.500 1.094
2014-03-21 0.500 1.106
2014-03-20 0.500 0.921
2013-03-22 1.000 1.998
2012-08-07 0.850 1.339
2012-07-16 0.850 1.512
2012-03-20 0.850 1.537
2011-03-17 0.700 1.479
2010-11-16 0.500 0.910
2010-03-03 0.500 1.342
2009-04-20 0.500 2.329

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of LANXESS's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (2.2x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (3.9x coverage).
X
Income/ dividend checks
We assess LANXESS's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can LANXESS afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. LANXESS has a total score of 4/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

LXS Management

 What is the CEO of LANXESS's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Matthias Zachert
COMPENSATION €4,825,000
AGE 51
TENURE AS CEO 5 years
CEO Bio

Mr. Matthias Zachert serves as the Chairman of Executive Board at Rhein Chemie Rheinau GmbH. Mr. Zachert has been the Chairman of the Board of Management at Lanxess AG since April 1, 2014. He serves as Chairman of the Executive Board at LANXESS Deutschland GmbH. He serves as a Member of Global Board of Management at LANXESS Corporation. Mr. Zachert served as the Chief Financial Officer and Member of Executive Board at Merck KGaA since June 2011 and served as its General Partner. From 1999 to 2002, he served as Chief Financial Officer of the International Region of Aventis Pharma AG. Mr. Zachert served as a Member of Executive Board at Merck Spol. S R.O. and at Merck S.A. (Chile). He served as the Chief Financial Officer of Lanxess AG from September 16, 2004 to March 31, 2011 and served as its Member of the Board of Management until March 31, 2011. He served as the Chief Financial Officer and Member of the Board of Management at LANXESS Sybron Chemicals Inc. He served as a Member of the Board of Management at LANXESS Elastômeros do Brasil S.A and served as its Chief Financial Officer since September 16, 2004. He served as a Member of the Management Board of Lieken AG from July 1, 2002 to May 1, 2004 and served its Chief Financial Officer from 2002 to April 30, 2004. Mr. Zachert served as an Executive Officer of Investor Relations and IT and Executive of Legal Affairs at Lieken AG until April 30, 2004. Since January 2000, he served as the Chief Financial Officer of the Region International of Kamps. He served as Commercial Assistant and Industrial Business Assistant at Mercedes Benz AG in Stuttgart. From 1990 to 1995, he also spent periods in the United States and France. He held various senior management positions in the pharmaceutical business of Hoechst AG. He served as Chief Financial Officer at Kamps AG. He has been a Member of Supervisory Board at Siemens AG and Siemens Aktiensgesellschaft since January 31, 2018. He serves as Director of LANXESS Elastômeros do Brasil S.A. He is Member of the executive committee of the association of German chemical companies VCI; Member of the German-Asia Pacific Business Association (APA); and Member of the executive committee of the non-profit think tank Stiftung Neue Verantwortung. Mr. Zachert completed an industrial management apprenticeship at Mercedes-Benz AG before he studied business administration with a concentration in finance and international management from 1990 to 1995. He graduated with a degree in business administration (Diplom-Kaufmann).

CEO Compensation
  • Matthias's compensation has been consistent with company performance over the past year.
  • Insufficient data for Matthias to establish whether their remuneration is reasonable compared to companies of similar size in .
Management Team Tenure

Average tenure and age of the LANXESS management team in years:

4.3
Average Tenure
54.5
Average Age
  • The tenure for the LANXESS management team is about average.
Management Team

Matthias Zachert

TITLE
Chairman of the Board of Management & CEO
COMPENSATION
€5M
AGE
51
TENURE
5 yrs

Michael Pontzen

TITLE
CFO & Member of the Board of Management
COMPENSATION
€2M
AGE
49
TENURE
4 yrs

Rainier van Roessel

TITLE
Labor Relations Director & Member of the Board of Management
COMPENSATION
€2M
AGE
61
TENURE
12.3 yrs

Hubert Fink

TITLE
Member of the Board of Management
COMPENSATION
€2M
AGE
56
TENURE
3.5 yrs

André Simon

TITLE
Head of Investor Relations

Luis Lopez-Remon

TITLE
Head of Leather Business Unit

Jorge Nogueira

TITLE
Head of Tire & Speciality Rubbers Business Unit
AGE
67
TENURE
4.3 yrs

Michael Zobel

TITLE
Head of High Performance Materials Business Unit

Jörg Hellwig

TITLE
Head of Inorganic Pigments Business Unit
AGE
53

Wolfgang Schmitz

TITLE
Managing Director of Saltigo Gmbh
Board of Directors Tenure

Average tenure and age of the LANXESS board of directors in years:

3.9
Average Tenure
60.5
Average Age
  • The tenure for the LANXESS board of directors is about average.
Board of Directors

Matthias Wolfgruber

TITLE
Chairman of Supervisory Board
COMPENSATION
€139K
AGE
64
TENURE
0.9 yrs

Ralf Sikorski

TITLE
Vice Chairman of Supervisory Board
COMPENSATION
€182K
AGE
57

Rolf Heinrich Stomberg

TITLE
Honorary Chairman of Supervisory Board
COMPENSATION
€262K
AGE
78
TENURE
0.9 yrs

Friedrich Janssen

TITLE
Member of Supervisory Board
COMPENSATION
€179K
AGE
70
TENURE
14.3 yrs

Werner Czaplik

TITLE
Member of Supervisory Board
COMPENSATION
€140K
AGE
61
TENURE
3.9 yrs

Theo Walthie

TITLE
Member of the Supervisory Board
COMPENSATION
€188K
AGE
71
TENURE
8.9 yrs

Thomas Meiers

TITLE
Member of Supervisory Board
COMPENSATION
€140K
AGE
45
TENURE
7.8 yrs

Hans-Dieter Gerriets

TITLE
Member of Supervisory Board
COMPENSATION
€140K
AGE
59
TENURE
4.8 yrs

Larry Rosen

TITLE
Member of Supervisory Board
COMPENSATION
€139K
AGE
60
TENURE
3.9 yrs

Manuela Strauch

TITLE
Member of Supervisory Board
COMPENSATION
€142K
AGE
47
TENURE
3.8 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess LANXESS's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. LANXESS has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

LXS News

Simply Wall St News

LXS Company Info

Description

LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals. The Specialty Additives segment provides additives, including lubricants, flame retardants, plasticizers, and bromine derivatives for various applications in the rubber, plastic, and paint industries. The Performance Chemicals segment offers material protection products; and inorganic pigments for the coloring of concrete, and emulsion paint and other coatings. It also offers finishing agents for the leather industry; and reverse osmosis membranes and ion exchange resins for water treatment, as well as disinfectant and hygiene solutions. The Engineering Materials segment produces technical plastics, glass fibers, fiber composites, and elastomers on a urethane basis for application in the automotive and electrical/electronics, and construction and medicine industries, as well as sports and leisure sectors. The ARLANXEO segment provides specialty rubbers for use in high-quality rubber products in the automotive engineering, tires, and construction industries. The company was founded in 1863 and is headquartered in Cologne, Germany.

Details
Name: LANXESS Aktiengesellschaft
LXS
Exchange: WBAG
Founded: 1863
€4,939,490,503
90,235,486
Website: http://lanxess.com
Address: LANXESS Aktiengesellschaft
Kennedyplatz 1,
Cologne,
North Rhine-Westphalia, 50569,
Germany
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
XTRA LXS Bearer Shares XETRA Trading Platform DE EUR 31. Jan 2005
OTCPK LNXS.F Bearer Shares Pink Sheets LLC US USD 31. Jan 2005
DB LXS Bearer Shares Deutsche Boerse AG DE EUR 31. Jan 2005
LSE 0H7I Bearer Shares London Stock Exchange GB EUR 31. Jan 2005
SWX LXS Bearer Shares SIX Swiss Exchange CH CHF 31. Jan 2005
WBAG LXS Bearer Shares Wiener Boerse AG AT EUR 31. Jan 2005
BATS-CHIXE LXSD Bearer Shares BATS 'Chi-X Europe' GB EUR 31. Jan 2005
Number of employees
Current staff
Staff numbers
15,045
LANXESS employees.
Industry
Diversified Chemicals
Materials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/18 22:08
End of day share price update: 2019/04/18 00:00
Last estimates confirmation: 2019/04/18
Last earnings filing: 2019/03/14
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.